Sravan K. Vanamala

514 total citations
6 papers, 287 citations indexed

About

Sravan K. Vanamala is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Sravan K. Vanamala has authored 6 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Genetics. Recurrent topics in Sravan K. Vanamala's work include Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Mesenchymal stem cell research (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Sravan K. Vanamala is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Mesenchymal stem cell research (2 papers) and Tissue Engineering and Regenerative Medicine (2 papers). Sravan K. Vanamala collaborates with scholars based in United States. Sravan K. Vanamala's co-authors include Balaraman Kalyanaraman, Eugene A. Konorev, Shasi V. Kalivendi, Eugene Kaji, Joy Joseph, Jasti S. Rao, Shakuntla Seetharam, Raghunatha R. Yammani, Bellur Seetharam and Dzung H. Dinh and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Sravan K. Vanamala

6 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sravan K. Vanamala United States	6	147	141	71	36	30	6	287
Koh‐ichi Yuhki Japan	9	114 0.8×	142 1.0×	55 0.8×	33 0.9×	22 0.7×	14	327
Sarath Meduru United States	11	140 1.0×	79 0.6×	35 0.5×	55 1.5×	17 0.6×	15	351
Gustav Holmgren Sweden	10	238 1.6×	88 0.6×	48 0.7×	10 0.3×	19 0.6×	14	441
Ana Reis-Mendes Portugal	10	72 0.5×	112 0.8×	60 0.8×	21 0.6×	15 0.5×	25	228
Lifeng Wang China	8	140 1.0×	58 0.4×	20 0.3×	16 0.4×	21 0.7×	13	272
Lorenzo Prever Italy	4	121 0.8×	83 0.6×	84 1.2×	31 0.9×	16 0.5×	5	259
Takehiko Kuramochi Japan	9	167 1.1×	251 1.8×	36 0.5×	28 0.8×	17 0.6×	16	361
P-F Li China	8	541 3.7×	110 0.8×	40 0.6×	55 1.5×	13 0.4×	8	699
Luca Sorvillo Italy	10	191 1.3×	30 0.2×	92 1.3×	31 0.9×	10 0.3×	10	343
Christina Schulz Canada	4	103 0.7×	58 0.4×	63 0.9×	23 0.6×	5 0.2×	8	323

Countries citing papers authored by Sravan K. Vanamala

Since Specialization

Citations

This map shows the geographic impact of Sravan K. Vanamala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sravan K. Vanamala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sravan K. Vanamala more than expected).

Fields of papers citing papers by Sravan K. Vanamala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sravan K. Vanamala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sravan K. Vanamala. The network helps show where Sravan K. Vanamala may publish in the future.

Co-authorship network of co-authors of Sravan K. Vanamala

This figure shows the co-authorship network connecting the top 25 collaborators of Sravan K. Vanamala. A scholar is included among the top collaborators of Sravan K. Vanamala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sravan K. Vanamala. Sravan K. Vanamala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Vanamala, Sravan K., et al.. (2010). Human umbilical cord blood derived stem cells repair doxorubicin-induced pathological cardiac hypertrophy in mice. Biochemical and Biophysical Research Communications. 395(3). 367–372. 17 indexed citations

2.

Vanamala, Sravan K., et al.. (2009). Effect of human umbilical cord blood cells on Ang-II-induced hypertrophy in mice. Biochemical and Biophysical Research Communications. 386(2). 386–391. 6 indexed citations

3.

Vanamala, Sravan K., et al.. (2009). Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. Cellular and Molecular Life Sciences. 66(24). 3967–3978. 23 indexed citations

4.

Konorev, Eugene A., Sravan K. Vanamala, & Balaraman Kalyanaraman. (2008). Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radical Biology and Medicine. 45(12). 1723–1728. 53 indexed citations

5.

Kalivendi, Shasi V., Eugene A. Konorev, Sravan K. Vanamala, et al.. (2005). Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochemical Journal. 389(2). 527–539. 170 indexed citations

6.

Vanamala, Sravan K., Shakuntla Seetharam, Raghunatha R. Yammani, & Bellur Seetharam. (2003). Human transcobalamin II receptor binds to Staphylococcus aureus protein A: Implications as to its structure and function. Archives of Biochemistry and Biophysics. 411(2). 204–214. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact